Our protocol, "The relationship between peak experience and outcome in (LSD) assisted psychotherapy with substance abusers, a double-blind controlled study" has received final approval from the FDA. Our facility has been approved for securely storing LSD, and we are negotiating with the National Institute on Drug Abuse (NIDA) for a supply of LSD. Progress on the study will be reported in an upcoming issue of MAPS.
Richard Yensen, Ph.D.
Donna Dryer, MD
Orenda Institute
[an error occurred while processing this directive]